Table 1

Baseline characteristics of patients with stage C or D heart failure with non-ischaemic dilated cardiomyopathy but without AF

Mean+SD/Median and IQRsAll patients (n=192)
Age, mean (SD) (years)53±14
Male (%)140 (72.92%)
BMI, mean (SD) (kg/m2)26.09±5.18
Hypertension (%)78 (41.27%)
Diabetes mellitus (%)28 (14.81%)
CKD (%)2 (1.06%)
LBBB on EKG (%)33 (17.65%)
RBBB on EKG (%)9 (4.81%)
Intraventricular block on EKG (%)13 (6.91%)
QRS duration mean (SD) (ms)124.18±31.62
Alanine aminotransferase (ALT) (U/L)33.39±33.63
Aspartate aminotransferase (AST) (U/L)28.90±24.46
Creatinine mean (SD) (mmol/L)82.53±25.22
Na+ (SD) (mmol/L)139.83±2.59
Cl (SD) (mmol/L)102.76±4.60
hs-CRP mean (SD) (mmol/L)3.53±5.42
Homocysteine (μmol/L)23.43±32.48
White blood cell (G/L)6.83±1.83
Haemoglobin (G/L)147.76±19.72
Platelets (G/L)210.08±64.24
BNP (pg/mL)245.50 (129.75–514.25)
CMR-LVEDV (mL)293±110
CMR-LVESV (mL)233±104
CMR-LVEF, (%)22.37±9.75
CMR-LVMASS (g)150.54±49.02
CMR-RVEDV (mL)135±44
CMR-RVESV (mL)96±41
CMR-RVEF (%)30.35±14.11
CMR-LVpGLS (%)−6.12±2.78
CMR-LVpGCS (%)−7.19±2.89
CMR-RVpGCS (%)−7.71±3.76
CMR-RVpGLS (%)−10.49±5.16
CMR-LVLGE (%)64 (33.51%)
 ACEI/ARB/ARNI (%)176 (91.57%)
 Beta-blocker (%)184 (95.83%)
 Spironolactone (%)172 (89.58%)
  • ACEI, ACE inhibitor; AF, atrial fibrillation; ARB, angiotensin II receptor blocker; ARNI, angiotensin receptor neprilysin inhibitor; ; BMI, body mass index; BNP, brain natriuretic peptide; CKD, chronic kidney disease; CMR, cardiac magnetic resonance; hs-CRP, high-sensitivity C reactive protein; LBBB, left bundle branch block; LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; LVESV, left ventricular end-systolic volume; LVLGE, left ventricular late gadolinium enhancement; LVMASS, left ventricular mass; LVpGCS, left ventricular peak global circumferential strain; LVpGLS, left ventricular peak global longitudinal strain; RBBB, right bundle branch block; RVEDV, right ventricular end-diastolic volume; RVEF, right ventricular ejection fraction; RVESV, right ventricular end-systolic volume; RVpGCS, right ventricular peak global circumferential strain; RVpGLS, right ventricular peak global longitudinal strain.